The Pharmacy Times® Pharmacy Hospital Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.
January 22nd 2025
Vusolimogene oderparepvec in combination with nivolumab is being assessed to treat individuals with unresectable or metastatic stage IIIb-IV cutaneous melanoma.
Brexanolone and Zuranolone for the Treatment of Postpartum Depression
July 9th 2024The American College of Clinical Gynecology recommends consideration of brexanolone or zuranolone in postpartum patients with onset of moderate-to-severe perinatal depression in the third trimester or within 4 weeks postpartum.
Read More
Data-Driven Development: How Real-World Data and AI Are Transforming Clinical Trials
July 6th 2024Real-world data and artificial intelligence (AI) are poised to revolutionize drug development by optimizing clinical trials and regulatory approvals, if data quality and patient privacy challenges are addressed.
Read More
Insights on the UK's MHRA International Recognition Procedure
The UK’s Medicine and Healthcare Products Regulatory Agency (MHRA) introduced changes to streamline its drug approval processes.
Read More
Pharmacists Play Essential Role in Managing Dupilumab for Chronic Obstructive Pulmonary Disease
July 3rd 2024As dupilumab garners positive clinical trial results in patients with chronic obstructive pulmonary disease, it is increasingly important that pharmacists educate themselves on the treatment.
Read More
Odronextamab Demonstrates Durable Responses in Patients With R/R FL, DLBCL in Ongoing Trial
July 2nd 2024The results are promising for patients with relapsed or refractory follicular lymphoma and diffuse large B-cell lymphoma, and the trial is ongoing to assess the efficacy of odronextamab in other subtypes.
Read More
ACIP Votes to Recommend Pneumococcal 21-Valent Conjugate Vaccine for Adult Populations
July 2nd 2024The committee, after being presented evidence by the working group, recommended the vaccine for adults aged 65 and older and those 19 or older who have current recommendations to receive a pneumococcal vaccine.
Read More
IVIG, Plasmapheresis Effective in Managing Non-Tumor Anti-Tr/DNER Antibody-Associated Ataxia
July 2nd 2024In a rare case of non-tumor anti-Tr/DNER antibody-associated ataxia, the patient is treated with plasmapheresis and intravenous immunoglobulin (IVIG) for symptoms such as dysarthria and difficulty walking.
Read More
What’s Complicating Good Data Practices and Data Integrity?
July 1st 2024As the data management landscape continues to shift and change with AI and technological advancements all around us, it is essential to maintain good data practices and ensure data integrity in pharmaceutical research and development.
Read More
Babies of Mothers Prescribed GLP-1s Prior to Pregnancy May Have Increased Risk of NICU Stays
July 1st 2024Additionally, birth weight was higher in babies born to mothers who were prescribed glucagon-like peptide-1 (GLP-1) medications either 90 days prior to pregnancy or during the first trimester.
Read More